Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (121-130 of 258) with videos related to

Pageof 26
Sort By:
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2025
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Joanne Ngeow, Jianbang Chiang, Esteban Astiazaran-Symonds, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variantsLucy Loong, Cankut Cubuk, Subin Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology GuidelineIsabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approachMarc Tischkowitz, Nancy Hamel, Marcelo A Carvalho, et al.
Nature Communications|September 4, 2024
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utilityShadi Basyuni, Laura Heskin, Andrea Degasperi, et al.
The Lancet Regional Health. Europe|May 15, 2024
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort studyIsaac Allen, Hend Hassan, Walburga Yvonne Joko-Fru, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Pageof 26

Showing results (121-130 of 258) with videos related to

Sort By:
Pageof 26
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2025
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Joanne Ngeow, Jianbang Chiang, Esteban Astiazaran-Symonds, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variantsLucy Loong, Cankut Cubuk, Subin Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology GuidelineIsabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz, et al.
European Journal of Human Genetics : EJHG|February 21, 2008
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approachMarc Tischkowitz, Nancy Hamel, Marcelo A Carvalho, et al.
Nature Communications|September 4, 2024
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utilityShadi Basyuni, Laura Heskin, Andrea Degasperi, et al.
The Lancet Regional Health. Europe|May 15, 2024
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort studyIsaac Allen, Hend Hassan, Walburga Yvonne Joko-Fru, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Pageof 26